Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arcera
Abu Dhabi, United Arab Emiratesarceralifesciences.com ↗
- Ownership
- Private
- Employees
- ~6500
- Development stage
- Commercial
01
Overview
Arcera is an active global life sciences company formed in 2024 by ADQ through the consolidation of Acino (Switzerland), Birgi Mefar Group (Türkiye), and Amoun Pharmaceutical Company (Egypt). It operates in more than 90 countries with over 6,500 employees. Its commercial-stage portfolio spans more than 2,000 branded medicines across multiple therapeutic areas. In June 2025 it signed an exclusive licensing deal for AR1001 for early-stage Alzheimer’s disease with AriBio covering Latin America, Middle East, Southern Africa, Ukraine and parts of Eurasia—a deal valued up to $600 million based on milestones[2][3][5].
- Therapeutic areas
- GastroenterologyCardiovascularNeurology
- Modalities
- Small moleculeBiologic
- Industry
- Pharma
02
Partnerships
AriBio – exclusive licensing/supply agreement for AR1001 in select regions ($600M milestone value)
Beyond the preview
Go deeper on Arcera.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Arcera.